Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ) Social Stream
JAZZ PHARMACEUTICALS PLC (JAZZ) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering JAZZ PHARMACEUTICALS PLC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 15 | $250 | $172 | $204.937 | $153 | 33.95% |
| 2021-11-11 | 15 | $250 | $172 | $204.312 | $153 | 33.54% |
| 2021-11-16 | 15 | $250 | $172 | $204.125 | $153 | 33.42% |
| 2021-12-17 | 14 | $250 | $172 | $203.812 | $153 | 33.21% |
| 2021-12-20 | 14 | $250 | $172 | $201.937 | $153 | 31.98% |
| 2022-01-06 | 14 | $250 | $172 | $202.312 | $153 | 32.23% |
| 2022-01-13 | 14 | $250 | $172 | $202.812 | $153 | 32.56% |
| 2022-01-23 | 14 | $250 | $172 | $204.562 | $153 | 33.7% |
| 2022-02-11 | 12 | $250 | $172 | $204.437 | $153 | 33.62% |
| 2022-02-25 | 11 | $250 | $172 | $204.437 | $153 | 33.62% |
| 2022-03-02 | 12 | $250 | $172 | $202.866 | $153 | 32.59% |
| 2022-03-04 | 14 | $250 | $172 | $202.266 | $153 | 32.2% |
| 2022-03-28 | 14 | $250 | $174 | $203.466 | $153 | 32.98% |
| 2022-04-22 | 14 | $250 | $174 | $204.357 | $153 | 33.57% |
| 2022-04-28 | 14 | $250 | $174 | $203.785 | $153 | 33.19% |
| 2022-05-06 | 14 | $250 | $174 | $205.285 | $153 | 34.17% |
| 2022-06-02 | 15 | $250 | $174 | $203.666 | $153 | 33.12% |
| 2022-06-14 | 16 | $250 | $174 | $203.062 | $153 | 32.72% |
| 2022-08-01 | 15 | $225 | $174 | $199.933 | $153 | 30.68% |
| 2022-09-17 | 16 | $225 | $183 | $200.437 | $153 | 31% |
| 2022-09-21 | 16 | $225 | $148 | $197.437 | $153 | 29.04% |
| 2022-09-29 | 15 | $225 | $170 | $198.812 | $153 | 29.94% |
| 2022-10-20 | 14 | $225 | $170 | $196.933 | $153 | 28.71% |
| 2022-11-02 | 14 | $225 | $170 | $197.133 | $153 | 28.85% |
| 2022-11-11 | 16 | $225 | $180 | $199.437 | $153 | 30.35% |
The Trend in the Analyst Price Target
Over the past 29 months, JAZZ's average price target has gone up $45.44.
JAZZ reports an average of 39.47% for its upside potential over the past 47 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-20 | 14 | 250 | 172 | 201.937 | 126.50 | 59.63% |
| 2022-03-28 | 14 | 250 | 174 | 203.466 | 158.15 | 28.65% |
| 2022-04-28 | 14 | 250 | 174 | 203.785 | 161.19 | 26.43% |
| 2022-10-21 | 14 | 225 | 170 | 197.133 | 135.01 | 46.01% |
| 2022-11-11 | 16 | 225 | 180 | 199.437 | 149.15 | 33.72% |
JAZZ Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.38 | 12 | 2 | 2 | 0 | 0 | 16 |
The Trend in the Broker Recommendations
JAZZ's average broker recommendation rating improved by 0.43 over the prior 14 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for JAZZ as an investment opportunity.
- In the context of all US stocks, JAZZ PHARMACEUTICALS PLC's average analyst price target is greater than 3215.48% of them.
- JAZZ PHARMACEUTICALS PLC's number of analysts covering the stock is greater than 3245.63% of Pharmaceutical Products stocks.
- In terms of how JAZZ PHARMACEUTICALS PLC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 688.25% of that group.
- In the context of Pharmaceutical Products stocks, JAZZ PHARMACEUTICALS PLC's variance in analysts' estimates is lower than -724.87% of them.
In the Pharmaceutical Products industry, BMRN, VRTX, and RPRX are the three stocks most similar to JAZZ PHARMACEUTICALS PLC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding JAZZ using the data that counts. Try POWR Ratings for free.